19.11.2008
Technical Board of Appeal maintains two “Myriad/breast cancer” patents in limited form
An EPO technical board of appeal has decided that the patent EP 699754, relating to a "Method for diagnosing a predisposition for breast and ovarian cancer", is to be maintained in an amended form, setting aside the 2004 first instance decision to revoke the patent.

18.11.2008
ip4inno has educated over 1 000 IP trainers
Over the past two years, the partners have developed 12 modules for these "multipliers" to use, which are available on a dedicated website.

17.11.2008
"Myriad/Breast cancer" gene case continues
A technical board of appeal will begin public oral proceedings in the appeal against the revocation of the "Myriad/breast cancer gene" patent in Munich this week.

14.11.2008
Trilateral offices move forward on work-sharing
The EPO, JPO and USPTO agreed to support the recently initiated co-operation of the five largest intellectual property offices, known as IP5.